BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Z, Cao Y, Tao Y, E M, Tang J, Liu Y, Li F. Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis. Diabetes Res Clin Pract. 2020;159:107990. [PMID: 31866530 DOI: 10.1016/j.diabres.2019.107990] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Van Hulten V, Rasmussen N, Driessen JHM, Burden AM, Kvist A, van den Bergh JP. Fracture Patterns in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review of Recent Literature. Curr Osteoporos Rep 2021;19:644-55. [PMID: 34931295 DOI: 10.1007/s11914-021-00715-6] [Reference Citation Analysis]
2 Prasathkumar M, Becky R, Anisha S, Dhrisya C, Sadhasivam S. Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches. Biotechnol Lett 2022. [PMID: 35119572 DOI: 10.1007/s10529-022-03232-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chai S, Liu F, Yang Z, Yu S, Liu Z, Yang Q, Sun F. Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Combining 177 Randomized Controlled Trials With a Median Follow-Up of 26 weeks. Front Pharmacol 2022;13:825417. [DOI: 10.3389/fphar.2022.825417] [Reference Citation Analysis]
4 Shi S, Ding F, Liu X, Wang L, Wang X, Zhang S, Zhao G, Song Y. Clinical and radiographic variables related to implants with simultaneous grafts among type 2 diabetic patients treated with different hypoglycemic medications: a retrospective study. BMC Oral Health 2021;21:214. [PMID: 33906655 DOI: 10.1186/s12903-021-01583-3] [Reference Citation Analysis]
5 Chin KY, Wong SK, Ekeuku SO, Pang KL. Relationship Between Metabolic Syndrome and Bone Health - An Evaluation of Epidemiological Studies and Mechanisms Involved. Diabetes Metab Syndr Obes 2020;13:3667-90. [PMID: 33116718 DOI: 10.2147/DMSO.S275560] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
6 Lee HS, Hwang JS. Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism. Curr Diab Rep 2020;20. [DOI: 10.1007/s11892-020-01361-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Castellano E, Attanasio R, Boriano A, Borretta V, Tassone F, Borretta G. Diabetes and Bone Involvement in Primary Hyperparathyroidism: Literature Review and Our Personal Experience. Front Endocrinol (Lausanne) 2021;12:665984. [PMID: 33953702 DOI: 10.3389/fendo.2021.665984] [Reference Citation Analysis]
8 Qian B, Chen Q, Li L, Yan C. Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials. Osteoporos Int 2020;31:2313-20. [DOI: 10.1007/s00198-020-05590-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Chiodini I, Gaudio A, Palermo A, Napoli N, Vescini F, Falchetti A, Merlotti D, Eller-Vainicher C, Carnevale V, Scillitani A, Pugliese G, Rendina D, Salcuni A, Bertoldo F, Gonnelli S, Nuti R, Toscano V, Triggiani V, Cenci S, Gennari L. Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel. Nutr Metab Cardiovasc Dis 2021;31:2210-33. [PMID: 34059385 DOI: 10.1016/j.numecd.2021.04.014] [Reference Citation Analysis]
10 Al-Mashhadi Z, Viggers R, Fuglsang-Nielsen R, de Vries F, van den Bergh JP, Harsløf T, Langdahl B, Gregersen S, Starup-Linde J. Glucose-Lowering Drugs and Fracture Risk-a Systematic Review. Curr Osteoporos Rep 2020;18:737-58. [PMID: 33165875 DOI: 10.1007/s11914-020-00638-8] [Reference Citation Analysis]
11 Kumari C, Yagoub G, Ashfaque M, Jawed S, Hamid P. Consequences of Diabetes Mellitus in Bone Health: Traditional Review. Cureus 2021;13:e13820. [PMID: 33850676 DOI: 10.7759/cureus.13820] [Reference Citation Analysis]
12 Cheng K, Guo Q, Yang W, Wang Y, Sun Z, Wu H. Mapping Knowledge Landscapes and Emerging Trends of the Links Between Bone Metabolism and Diabetes Mellitus: A Bibliometric Analysis From 2000 to 2021. Front Public Health 2022;10:918483. [DOI: 10.3389/fpubh.2022.918483] [Reference Citation Analysis]
13 Zhang SS, Zhang NN, Guo S, Liu SJ, Hou YF, Li S, Ho CT, Bai NS. Glycosides and flavonoids from the extract of Pueraria thomsonii Benth leaf alleviate type 2 diabetes in high-fat diet plus streptozotocin-induced mice by modulating the gut microbiota. Food Funct 2022;13:3931-45. [PMID: 35289350 DOI: 10.1039/d1fo04170c] [Reference Citation Analysis]
14 Schacter GI, Leslie WD. Diabetes and Osteoporosis: Part I, Epidemiology and Pathophysiology. Endocrinol Metab Clin North Am 2021;50:275-85. [PMID: 34023043 DOI: 10.1016/j.ecl.2021.03.005] [Reference Citation Analysis]
15 Palui R, Pramanik S, Mondal S, Ray S. Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus. World J Diabetes 2021; 12(6): 706-729 [PMID: 34168723 DOI: 10.4239/wjd.v12.i6.706] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]